discovery and predictive toxicology

Discovery and predictive toxicology

Helping to put the right drug candidate forward

Understanding mechanisms of action and predicting toxicity in drug candidates can help you define the most efficient testing strategy. Predictive toxicology screening can highlight areas where candidate molecules have potential issues at a very early stage, facilitating drug candidate selection for further pre-clinical development.

Predictive toxicology screening for structuring formal testing packages; some examples:

  • Dermal screening for potential skin sensitisation and dermal irritation
  • QSAR for genotoxicity assessment
  • Toxicogenomics to assess potential hepatotoxicity

Our priority is accompanying you in your preclinical compound development, so we are always happy to advise you on drug candidate selection packages using our discovery and predictive toxicology services. Follow the links below for further information:

In silico and QSAR

In vitro toxicology

Genetic toxicology

Early screening and lead optimization


Stem cells and metobolomics